20 February 2026
20 February 2026
The NanoKnife system employs non-thermal IRE ablation to destroy tumour cells while preserving surrounding anatomy.
The collaboration will combine Syngene’s preclinical development expertise with VivaMed's AI-generated therapeutic hypotheses.
NG Biotech manufactured the assays in France, with Hardy Diagnostics serving as the exclusive distributor in the US.
MSD will integrate clinical insights and genomic datasets from Mayo Clinic Platform, aggregating data in a secure environment.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
